Search research articles
Contact Us
Filters
Showing results (481-490 of 622) with videos related to
Page
of 63
Sort By:
Acta Oncologica (Stockholm, Sweden)
|
February 15, 2021
Adjuvant therapy following neoadjuvant chemotherapy and surgery for oesophageal adenocarcinoma in patients with clear resection margins
Rebecca K Bott, Kerri Beckmann, Janine Zylstra, et al.
British Journal of Haematology
|
May 22, 2020
Prognostic indices in diffuse large B-cell lymphoma in the rituximab era: an analysis of the UK National Cancer Research Institute R-CHOP 14 versus 21 phase 3 trial
Mary Gleeson, Nicholas Counsell, David Cunningham, et al.
British Journal of Cancer
|
April 21, 2026
Maintenance capecitabine after first-line platinum-based chemotherapy in advanced oesophagogastric adenocarcinoma: final analysis from the PLATFORM trial
Anderley Gordon, Amina Tran, Caroline Fong, et al.
British Journal of Haematology
|
August 2, 2016
Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone (R-CHOP) in the management of primary mediastinal B-cell lymphoma: a subgroup analysis of the UK NCRI R-CHOP 14 versus 21 trial
Mary Gleeson, Eliza A Hawkes, David Cunningham, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 6, 2018
Progression-Free Survival as a Surrogate End Point for Overall Survival in First-Line Diffuse Large B-Cell Lymphoma: An Individual Patient-Level Analysis of Multiple Randomized Trials (SEAL)
Qian Shi, Norbert Schmitz, Fang-Shu Ou, et al.
The British Journal of Surgery
|
May 13, 2022
Author response to: Increasing frequency of gene copy number aberrations is associated with immunosuppression and predicts poor prognosis in gastric adenocarcinoma
Arnaldo N S Silva, Yuichi Saito, Takaki Yoshikawa, et al.
The Journal of Molecular Diagnostics : JMD
|
March 10, 2015
Technical reproducibility of single-nucleotide and size-based DNA biomarker assessment using DNA extracted from formalin-fixed, paraffin-embedded tissues
Shenli Zhang, Iain B Tan, Nur S Sapari, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 28, 2009
Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer
David Cunningham, Ian Chau, Deborah D Stocken, et al.
The Lancet. Oncology
|
September 22, 2014
Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial
Hansjochen Wilke, Kei Muro, Eric Van Cutsem, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 27, 2012
Breast cancer risk after supradiaphragmatic radiotherapy for Hodgkin's lymphoma in England and Wales: a National Cohort Study
Anthony J Swerdlow, Rosie Cooke, Andrew Bates, et al.
Page
of 63
Search research articles
Search
Showing results (481-490 of 622) with videos related to
Sort By:
Page
of 63
Acta Oncologica (Stockholm, Sweden)
|
February 15, 2021
Adjuvant therapy following neoadjuvant chemotherapy and surgery for oesophageal adenocarcinoma in patients with clear resection margins
Rebecca K Bott, Kerri Beckmann, Janine Zylstra, et al.
British Journal of Haematology
|
May 22, 2020
Prognostic indices in diffuse large B-cell lymphoma in the rituximab era: an analysis of the UK National Cancer Research Institute R-CHOP 14 versus 21 phase 3 trial
Mary Gleeson, Nicholas Counsell, David Cunningham, et al.
British Journal of Cancer
|
April 21, 2026
Maintenance capecitabine after first-line platinum-based chemotherapy in advanced oesophagogastric adenocarcinoma: final analysis from the PLATFORM trial
Anderley Gordon, Amina Tran, Caroline Fong, et al.
British Journal of Haematology
|
August 2, 2016
Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone (R-CHOP) in the management of primary mediastinal B-cell lymphoma: a subgroup analysis of the UK NCRI R-CHOP 14 versus 21 trial
Mary Gleeson, Eliza A Hawkes, David Cunningham, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 6, 2018
Progression-Free Survival as a Surrogate End Point for Overall Survival in First-Line Diffuse Large B-Cell Lymphoma: An Individual Patient-Level Analysis of Multiple Randomized Trials (SEAL)
Qian Shi, Norbert Schmitz, Fang-Shu Ou, et al.
The British Journal of Surgery
|
May 13, 2022
Author response to: Increasing frequency of gene copy number aberrations is associated with immunosuppression and predicts poor prognosis in gastric adenocarcinoma
Arnaldo N S Silva, Yuichi Saito, Takaki Yoshikawa, et al.
The Journal of Molecular Diagnostics : JMD
|
March 10, 2015
Technical reproducibility of single-nucleotide and size-based DNA biomarker assessment using DNA extracted from formalin-fixed, paraffin-embedded tissues
Shenli Zhang, Iain B Tan, Nur S Sapari, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 28, 2009
Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer
David Cunningham, Ian Chau, Deborah D Stocken, et al.
The Lancet. Oncology
|
September 22, 2014
Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial
Hansjochen Wilke, Kei Muro, Eric Van Cutsem, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 27, 2012
Breast cancer risk after supradiaphragmatic radiotherapy for Hodgkin's lymphoma in England and Wales: a National Cohort Study
Anthony J Swerdlow, Rosie Cooke, Andrew Bates, et al.
Page
of 63